search
Back to results

Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes

Primary Purpose

Smoking

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Leading U.S. non-menthol cigarette
Leading U.S. menthol cigarette
Electronic cigarette #1
Electronic cigarette #2
Electronic cigarette #3
U.S. Market-sample electronic cigarettes
Sponsored by
R.J. Reynolds Vapor Company
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Smoking focused on measuring electronic cigarettes, e-cigarettes, combustible cigarettes, second-hand smoke, environmental tobacco smoke, tobacco-burning

Eligibility Criteria

21 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Able to read, understand, and willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English.
  2. Generally healthy males or females, 21 years of age or older at Screening.
  3. Able to meet cohort-specific requirements as follows:

    Cohort 1 - Leading U.S. tobacco-burning non-menthol cigarette, and

    Cohort 2 - Leading U.S. tobacco-burning menthol cigarette:

    • self-reports at the Screening Visit smoking at least 5 cigarettes per day and inhaling the smoke, for at least 3 months prior to Screening
    • self-reports smoking Leading U.S. tobacco-burning non-menthol cigarette or Leading U.S. tobacco-burning menthol cigarette as usual brand (UB) cigarettes [UB cigarette is defined as the cigarette brand style currently smoked most frequently by the participant];

    Cohort 3 - Electronic cigarette #1 smokers, and

    Cohort 4 - Electronic cigarette #2 smokers:

    • self-reports at the Screening Visit smoking a non-menthol e-cigarette at least once per day, for at least 3 months prior to Screening;
    • willing to switch from using their current e-cigarette brand style to using a different e-cigarette brand style during the study;

    Cohort 5 - Electronic cigarette #3 smokers:

    • self-reports at the Screening Visit smoking a menthol e-cigarette at least once per day, for at least 3 months prior to Screening;
    • willing to switch from using their current e-cigarette brand style to using a different e-cigarette brand style during the study;

    Cohort 6 - U.S Market-sample electronic cigarette smokers:

    • self-reports at the Screening Visit smoking the selected U.S. market-sample e-cigarettes (menthol or non-menthol) at least once per day, for at least three months prior to Screening;
    • willing to continue exclusive use of their preferred style (flavor) of e-cigarette during the study.
  4. Females of childbearing potential must be willing to use a form of contraception acceptable to the Investigator from the time of signing informed consent until study discharge or be surgically sterile for at least 90 days prior to enrollment;
  5. Able to safely perform the required study procedures, as determined by the Investigator.

Exclusion Criteria:

  1. Clinically significant or unstable/uncontrolled acute or chronic medical conditions at Screening, as determined by the Investigator, that would preclude a participant from participating safely in the study (e.g., hypertension, asthma, or other lung disease; cardiac disease; neurological disease; or psychiatric disorders) based on screening assessments such as safety labs and medical history or physical examination at Enrollment;
  2. Self-reports or safety labs indicate diabetes;
  3. At risk for heart disease, as determined by the Investigator;
  4. Use of medicine for treatment of depression or asthma;
  5. Systolic blood pressure of ≥150 mmHg or a diastolic blood pressure of ≥95 mmHg, measured after being seated for 5 minutes;
  6. Postponing a decision to quit smoking (defined as planning a quit attempt within 30 days of the Screening Visit) to participate in this study;
  7. Employed by a tobacco company, the study site, or environmental test chamber vendor;
  8. Females who have a positive pregnancy test, are pregnant, breastfeeding, or intend to become pregnant during the course of the study;
  9. History of claustrophobia;
  10. Regularly exposed to solvent fumes or gasoline (e.g., painter, gas-station mini mart employee);
  11. Determined by the Investigator to be inappropriate for this study, including a participant who is unable to communicate or unwilling to cooperate with the clinical staff.

Sites / Locations

  • Clinical Research Atlanta

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Active Comparator

Active Comparator

Experimental

Experimental

Experimental

Experimental

Arm Label

Leading U.S. tobacco-burning non-menthol cigarette

Leading U.S. tobacco-burning menthol cigarette

Electronic cigarette #1

Electronic cigarette #2

Electronic cigarette #3

U.S. Market-sample electronic cigarettes (two brands)

Arm Description

Leading U.S. non-menthol cigarette

Leading U.S. menthol cigarette

VUSE® (menthol flavor, 29 mg nicotine)

VUSE® (original flavor, 29 mg nicotine)

VUSE® (original flavor, 14 mg nicotine)

blu™ (any variety) and NJOY® (any variety)

Outcomes

Primary Outcome Measures

To assess differences in levels of selected SHS constituents in an environmental test chamber after human smoking of e-cigarette #1, #2, and #3 compared to after human smoking of tobacco-burning cigarettes.

Secondary Outcome Measures

To determine selected SHS constituent emission factors for each tobacco-burning cigarette, each e-cigarette, and the market-sample e-cigarettes (collectively).
To assess the differences in levels of selected SHS constituents in an environmental test chamber after human smoking of e-cigarettes and tobacco-burning cigarettes compared to after a non-smoking blank condition.
To assess differences in levels of additional selected SHS constituents in an environmental test chamber after human smoking of e-cigarettes compared to after human smoking of tobacco-burning cigarettes.

Full Information

First Posted
July 7, 2014
Last Updated
May 31, 2018
Sponsor
R.J. Reynolds Vapor Company
Collaborators
Covance, R.J. Reynolds Tobacco Company, MAS (Materials Analytical Services), LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT02185898
Brief Title
Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes
Official Title
A Single-Center Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes
Study Type
Interventional

2. Study Status

Record Verification Date
May 2018
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
February 2015 (Actual)
Study Completion Date
February 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
R.J. Reynolds Vapor Company
Collaborators
Covance, R.J. Reynolds Tobacco Company, MAS (Materials Analytical Services), LLC

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will assess environmental emissions of selected compounds in a test chamber after cigarette smoking or e-cigarette vaping.
Detailed Description
Secondhand smoke is the aged and diluted combination of smoke exhaled by a smoker and sidestream smoke (smoke from the lit end of a cigarette). Electronic cigarettes are different from tobacco-burning cigarettes in that they produce vapor, not smoke. For consistency with common usage, secondhand smoke (SHS) refers to true secondhand smoke from cigarettes and secondhand vapor from e-cigarettes. The goals of this study are to 1) increase understanding of the composition of SHS from e-cigarettes, 2) quantitatively compare the amount of SHS generated by e-cigarettes and a market sample of commercial e-cigarettes to leading brand styles of commercial tobacco-burning cigarettes, and 3) quantitate the emission factors of e-cigarettes including the market-sample e-cigarettes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Smoking
Keywords
electronic cigarettes, e-cigarettes, combustible cigarettes, second-hand smoke, environmental tobacco smoke, tobacco-burning

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
71 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Leading U.S. tobacco-burning non-menthol cigarette
Arm Type
Active Comparator
Arm Description
Leading U.S. non-menthol cigarette
Arm Title
Leading U.S. tobacco-burning menthol cigarette
Arm Type
Active Comparator
Arm Description
Leading U.S. menthol cigarette
Arm Title
Electronic cigarette #1
Arm Type
Experimental
Arm Description
VUSE® (menthol flavor, 29 mg nicotine)
Arm Title
Electronic cigarette #2
Arm Type
Experimental
Arm Description
VUSE® (original flavor, 29 mg nicotine)
Arm Title
Electronic cigarette #3
Arm Type
Experimental
Arm Description
VUSE® (original flavor, 14 mg nicotine)
Arm Title
U.S. Market-sample electronic cigarettes (two brands)
Arm Type
Experimental
Arm Description
blu™ (any variety) and NJOY® (any variety)
Intervention Type
Other
Intervention Name(s)
Leading U.S. non-menthol cigarette
Other Intervention Name(s)
Marlboro Gold Pack Box
Intervention Description
Tobacco-burning non-menthol cigarette
Intervention Type
Other
Intervention Name(s)
Leading U.S. menthol cigarette
Other Intervention Name(s)
Newport Box
Intervention Description
Tobacco-burning menthol cigarette
Intervention Type
Other
Intervention Name(s)
Electronic cigarette #1
Other Intervention Name(s)
VUSE® Digital Vapor Cigarette (menthol flavor, 29 mg nicotine)
Intervention Description
Electronic cigarette
Intervention Type
Other
Intervention Name(s)
Electronic cigarette #2
Other Intervention Name(s)
VUSE® Digital Vapor Cigarette (original flavor, 29 mg nicotine)
Intervention Description
Electronic cigarette
Intervention Type
Other
Intervention Name(s)
Electronic cigarette #3
Other Intervention Name(s)
VUSE® Digital Vapor Cigarette (original flavor, 14 mg nicotine)
Intervention Description
Electronic cigarette
Intervention Type
Other
Intervention Name(s)
U.S. Market-sample electronic cigarettes
Other Intervention Name(s)
blu™ (any variety) and NJOY® (any variety)
Intervention Description
Marketed electronic cigarettes
Primary Outcome Measure Information:
Title
To assess differences in levels of selected SHS constituents in an environmental test chamber after human smoking of e-cigarette #1, #2, and #3 compared to after human smoking of tobacco-burning cigarettes.
Time Frame
2 weeks for participants in Cohorts 1 and 2; and approximately 4 weeks for participants in Cohorts 3, 4, and 5
Secondary Outcome Measure Information:
Title
To determine selected SHS constituent emission factors for each tobacco-burning cigarette, each e-cigarette, and the market-sample e-cigarettes (collectively).
Time Frame
2 weeks for participants in Cohorts 1, 2, and 6; and approximately 4 weeks for participants in Cohorts 3, 4, and 5
Title
To assess the differences in levels of selected SHS constituents in an environmental test chamber after human smoking of e-cigarettes and tobacco-burning cigarettes compared to after a non-smoking blank condition.
Time Frame
2 weeks for participants in Cohorts 1, 2, and 6; and approximately 4 weeks for participants in Cohorts 3, 4, and 5
Title
To assess differences in levels of additional selected SHS constituents in an environmental test chamber after human smoking of e-cigarettes compared to after human smoking of tobacco-burning cigarettes.
Time Frame
2 weeks for participants in Cohorts 1, 2, and 6; and approximately 4 weeks for participants in Cohorts 3, 4, and 5

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Able to read, understand, and willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English. Generally healthy males or females, 21 years of age or older at Screening. Able to meet cohort-specific requirements as follows: Cohort 1 - Leading U.S. tobacco-burning non-menthol cigarette, and Cohort 2 - Leading U.S. tobacco-burning menthol cigarette: self-reports at the Screening Visit smoking at least 5 cigarettes per day and inhaling the smoke, for at least 3 months prior to Screening self-reports smoking Leading U.S. tobacco-burning non-menthol cigarette or Leading U.S. tobacco-burning menthol cigarette as usual brand (UB) cigarettes [UB cigarette is defined as the cigarette brand style currently smoked most frequently by the participant]; Cohort 3 - Electronic cigarette #1 smokers, and Cohort 4 - Electronic cigarette #2 smokers: self-reports at the Screening Visit smoking a non-menthol e-cigarette at least once per day, for at least 3 months prior to Screening; willing to switch from using their current e-cigarette brand style to using a different e-cigarette brand style during the study; Cohort 5 - Electronic cigarette #3 smokers: self-reports at the Screening Visit smoking a menthol e-cigarette at least once per day, for at least 3 months prior to Screening; willing to switch from using their current e-cigarette brand style to using a different e-cigarette brand style during the study; Cohort 6 - U.S Market-sample electronic cigarette smokers: self-reports at the Screening Visit smoking the selected U.S. market-sample e-cigarettes (menthol or non-menthol) at least once per day, for at least three months prior to Screening; willing to continue exclusive use of their preferred style (flavor) of e-cigarette during the study. Females of childbearing potential must be willing to use a form of contraception acceptable to the Investigator from the time of signing informed consent until study discharge or be surgically sterile for at least 90 days prior to enrollment; Able to safely perform the required study procedures, as determined by the Investigator. Exclusion Criteria: Clinically significant or unstable/uncontrolled acute or chronic medical conditions at Screening, as determined by the Investigator, that would preclude a participant from participating safely in the study (e.g., hypertension, asthma, or other lung disease; cardiac disease; neurological disease; or psychiatric disorders) based on screening assessments such as safety labs and medical history or physical examination at Enrollment; Self-reports or safety labs indicate diabetes; At risk for heart disease, as determined by the Investigator; Use of medicine for treatment of depression or asthma; Systolic blood pressure of ≥150 mmHg or a diastolic blood pressure of ≥95 mmHg, measured after being seated for 5 minutes; Postponing a decision to quit smoking (defined as planning a quit attempt within 30 days of the Screening Visit) to participate in this study; Employed by a tobacco company, the study site, or environmental test chamber vendor; Females who have a positive pregnancy test, are pregnant, breastfeeding, or intend to become pregnant during the course of the study; History of claustrophobia; Regularly exposed to solvent fumes or gasoline (e.g., painter, gas-station mini mart employee); Determined by the Investigator to be inappropriate for this study, including a participant who is unable to communicate or unwilling to cooperate with the clinical staff.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nathan Segall, MD, CPI
Organizational Affiliation
Clinical Research Atlanta
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinical Research Atlanta
City
Stockbridge
State/Province
Georgia
ZIP/Postal Code
30281
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes

We'll reach out to this number within 24 hrs